Home › Funds › Blue Zone Wealth Advisors, LLC › WST

Blue Zone Wealth Advisors, LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Blue Zone Wealth Advisors, LLC reported holding 24,970 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 1.56% of its reported portfolio and ranking #15 among its reported holdings. Blue Zone Wealth Advisors, LLC has disclosed WST holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)24.97K sh
Reported value held$9.26M
Portfolio Weight1.56%
First reportedQ1 2024
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Blue Zone Wealth Advisors, LLC's WST position evolved

Blue Zone Wealth Advisors, LLC first disclosed a stake in WST in Q1 2024 at 9,707 shares (US$3.8M). The position peaked in Q2 2026 at 25,839 shares, worth US$9.3M. Across 11 filings, Blue Zone Wealth Advisors, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 24,970 shares valued at US$9.3M — a reduction of -869 shares quarter over quarter.. Notable position changes include a 66% increase in Q3 2024 (shares rose 9% over the following quarter), a 62% increase in Q1 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 9.71K $3.84M New
Q2 2024 9.96K $3.28M Add
Q3 2024 16.54K $4.96M Add
Q4 2024 17.04K $5.58M Add
Q1 2025 27.61K $6.18M Add
Q2 2025 28.36K $6.21M Add
Q3 2025 28.88K $7.58M Add
Q4 2025 29.25K $8.05M Add
Q1 2026 29.07K $7.29M Reduce
Q2 2026 25.84K $9.28M Reduce
Q3 2026 24.97K $9.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Blue Zone Wealth Advisors, LLC held WST?

Blue Zone Wealth Advisors, LLC has disclosed WST holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Blue Zone Wealth Advisors, LLC's current position in WST?

As of Q3 2026, Blue Zone Wealth Advisors, LLC holds 24.97K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $9.26M, representing 1.56% of its reported portfolio and ranking #15.

Has Blue Zone Wealth Advisors, LLC been buying or selling WST?

In the latest 13F filing (Q3 2026), Blue Zone Wealth Advisors, LLC reduced its position in WST. The position peaked in Q2 2026 at 25.84K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.